CoChat

Acute pancreatitis during GLP-1 receptor agonist treatment. A case report

Open access
Chis, Bogdan Augustin, Fodor, Daniela · 2018 · Medicine and Pharmacy Reports

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Glucagon-like peptide 1 receptor agonists (GLP-1RA) are the newest treatment for diabetes mellitus (DM). These drugs can down-regulate fasting glucose more than oral drugs and lead to more constant glucose levels compared to regular insulin. Acute pancreatitis is a serious condition that may have a fatal outcome. It has been shown that long term and high doses of GLP-1RA can cause pancreatic changes in animals, but no connection has been proven in humans. We present the case of a 67 years old man with DM treated with oral drugs for 10 years until 3 months before, when GLP-1RA was added. He presented progressive abdominal pain, vomiting, and increased level of serum lipase and amylase were found. Ultrasonography and computed tomography found pancreatic and peripancreatic fatty tissue inflammation (inflammation score 2, necrosis score 0). All the etiologies of acute pancreatitis (lithiasis, alcohol, autoimmune, or trauma) were excluded. After GLP-1RA cessation and supportive treatment the evolution was self-limited with full recovery within 5 days. We concluded that acute pancreatitis can be considered a side effect of the GLP-1 treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15386/cjmed-804

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 a) Ultrasonography longitudinal scan of the pancreas edema of the fatty tissue around the pancreas (arrows).
Figure 1 a) Ultrasonography longitudinal scan of the pancreas edema of the fatty tissue around the pancreas (arrows).CC BY-NC-ND · PubMed Central
Figure 1 b) computed tomography scan showing pancreatic edema between arrows (Balthazar C inflammation score).
Figure 1 b) computed tomography scan showing pancreatic edema between arrows (Balthazar C inflammation score).CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 1

  1. [9]ELIXA trial show CV safety of lixisenatide Available from: https://www.escardio.org/The-ESC/Press-Office/Press-releases/elixa-trial-shows-cv-safety-of-lixisenatide

Cited by

See all 26

Metadata

Authors
Chis, B. A., & Fodor, D.
Affiliations
Iuliu Hațieganu University of Medicine and Pharmacy (RO)
Venue
Medicine and Pharmacy Reports
Published
2018-01-30
Volume
91
Issue
1
Pages
117-119
ISSN
  • 2602-0807 (ISSN-L)
  • 2668-0572
OpenAlex
W2614450769
Cited by
26
References
13
Citations by year
2026: 1 · 2025: 6 · 2024: 4 · 2023: 1 · 2022: 3 · 2021: 5 · 2020: 3 · 2019: 2 · 2018: 1
FWCI
1.68
Type
journal article
Language
en
Open access
Locations
  • Medicine and Pharmacy Reports (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Keywords
acute pancreatitis, GLP-1 receptor agonists, glucagon-like peptide-1, drug-induced pancreatitis, adverse drug reactions, diabetes mellitus, pancreatitis, drug discontinuation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Acute pancreatitis during GLP-1 receptor agonist treatment. A case report. https://app.cochat.ai/papers/10.15386/cjmed-804
The paper
Chis, B. A., & Fodor, D. (2018). Acute pancreatitis during GLP-1 receptor agonist treatment. A case report. Medicine and Pharmacy Reports. https://doi.org/10.15386/cjmed-804

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.